Omnicell Inc
NASDAQ:OMCL
Omnicell Inc
NASDAQ:OMCL
Price:
32.245 USD
-1.18%
Market Closed
Updated:
May 28, 2024
Omnicell Inc
Selling, General & Administrative
|
Omnicell Inc
Selling, General & Administrative Peer Comparison
Comparables:
VEEV
INSP
DOCS
CERT
GDRX
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Selling, General & Administrative
-$397.8m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-11%
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Selling, General & Administrative
-$628m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-26%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Selling, General & Administrative
-$475.5m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Selling, General & Administrative
-$170m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
Certara Inc
NASDAQ:CERT
|
Selling, General & Administrative
-$127.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Selling, General & Administrative
-$465.1m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
See Also
What is Omnicell Inc's Selling, General & Administrative?
Selling, General & Administrative
-397.8m
USD
-397.8m
USD
Based on the financial report for Mar 31, 2024, Omnicell Inc's Selling, General & Administrative amounts to -397.8m USD.
What is Omnicell Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-11%
-11%
Over the last year, the Selling, General & Administrative growth was 17%. The average annual Selling, General & Administrative growth rates for Omnicell Inc have been -8% over the past three years , -8% over the past five years , and -11% over the past ten years .
You don't have any saved screeners yet
